HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Thomas H Cartwright Selected Research
Thomas H Cartwright Research Topics
Disease
7
Colorectal Neoplasms (Colorectal Cancer)
06/2013 - 05/2008
5
Neoplasms (Cancer)
01/2017 - 01/2002
2
Pancreatic Neoplasms (Pancreatic Cancer)
09/2018 - 01/2002
2
Hypertension (High Blood Pressure)
01/2013 - 12/2012
1
Cardiotoxicity
01/2017
1
Diarrhea
01/2017
1
Leukopenia
01/2017
1
Nausea
01/2017
1
Vomiting
01/2017
1
Mucositis
01/2017
1
Dihydropyrimidine Dehydrogenase Deficiency
01/2017
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2015
1
Peripheral Nervous System Diseases (PNS Diseases)
01/2013
1
Headache (Headaches)
01/2013
1
Carcinoma (Carcinomatosis)
12/2012
1
Colonic Neoplasms (Colon Cancer)
12/2012
1
Neutropenia
12/2012
1
Pain (Aches)
01/2002
Drug/Important Bio-Agent (IBA)
5
Capecitabine (Xeloda)
FDA Link
01/2017 - 01/2002
4
Bevacizumab (Avastin)
FDA Link
01/2013 - 09/2012
3
Fluorouracil (Carac)
FDA Link
Generic
01/2017 - 09/2012
2
Leucovorin (Folinic Acid)
FDA Link
12/2012 - 09/2012
2
Oxaliplatin (Eloxatin)
FDA Link
Generic
12/2012 - 09/2012
2
Panitumumab (Vectibix)
FDA Link
09/2012 - 05/2008
2
Cetuximab (Erbitux)
FDA Link
09/2012 - 05/2008
1
130-nm albumin-bound paclitaxel
IBA
09/2018
1
Gemcitabine
FDA Link
09/2018
1
folfirinox
IBA
09/2018
1
Enzymes
IBA
01/2017
1
uridine triacetate
IBA
01/2017
1
Carboplatin (JM8)
FDA Link
Generic
07/2015
1
Cisplatin (Platino)
FDA Link
Generic
07/2015
1
Dihydrotachysterol (AT 10)
IBA
07/2014
1
Angiogenesis Inhibitors
IBA
06/2013
1
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
01/2013
1
Axitinib (AG 013736)
IBA
01/2013
1
XELOX
IBA
12/2012
1
Irinotecan (Camptosar)
FDA Link
Generic
09/2012
1
Analgesics (Analgesic Drugs)
IBA
01/2002
Therapy/Procedure
7
Drug Therapy (Chemotherapy)
09/2018 - 05/2008
2
Therapeutics
01/2013 - 09/2012
1
Combination Drug Therapy (Combination Chemotherapy)
09/2018
1
Time-to-Treatment
09/2018
1
Adjuvant Chemotherapy
12/2012